Progress in immunocytochemical staining for cervical cancer screening

References

• BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAGlobal Cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin201868639442430207593
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• SaxenaUSauvagetCSankaranarayananREvidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low-resource countries: example of IndiaAsian Pac J Cancer Prev20121341699170322799391
   PubMedGoogle Scholar
• Committee on Practice Bulletins – GynecologyPractice Bulletin no. 168: cervical cancer screening and preventionJ Gynecol Obstet20161284e111e130
   PubMed Web of Science ®Google Scholar
• WrightTCJrStolerMHBehrensCMSharmaASharmaKAppleRInterlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trialInt J Cancer201413481835184324122508
   PubMed Web of Science ®Google Scholar
• MurphyJKennedyEBDunnSHPV testing in primary cervical screening: a systematic review and meta-analysisJ Obstet Gynaecol Can201234544345222555137
   PubMedGoogle Scholar
• HuhWKAultKAChelmowDUse of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceGynecol Oncol2015136217818225579107
   PubMed Web of Science ®Google Scholar
• GrahamSVThe human papillomavirus replication cycle, and its links to cancer progression: a comprehensive reviewClin Sci2017131172201222128798073
   PubMed Web of Science ®Google Scholar
• NayarRWilburDCThe Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory NotesNew YorkSpringer2015
   Google Scholar
• OrtegaSMalumbresMBarbacidMCyclin D-dependent kinases, INK4 inhibitors and cancerBiochim Biophys Acta200216021738711960696
   PubMed Web of Science ®Google Scholar
• PiccininSDoglioniCMaestroRp16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progressionInt J Cancer199774126309036865
   PubMed Web of Science ®Google Scholar
• ZhaoPHuYCTalbotICExpressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinomaWorld J Gastroenterol2003910220214562378
   PubMed Web of Science ®Google Scholar
• ZhouYGaoSSLiYXTumor suppressor gene p16 and Rb expression in gastric cardia precancerous lesions from subjects at a high incidence area in northern ChinaWorld J Gastroenterol20028342312046062
   PubMed Web of Science ®Google Scholar
• von Knebel DoeberitzMSearching for new biomarkers for cervical cancer: molecular accidents and the interplay of papillomavirus oncogenes and epithelial differentiation—Part 1Papillomavirus Rep20021323541
   Google Scholar
• DarraghTMColganTJCoxJTThe Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical PathologyArch Pathol Lab Med2012136101266129722742517
   PubMed Web of Science ®Google Scholar
• MurphyNRingMKillaleaAGP16INK4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep™ smearsJ Clin Pathol2003561566312499437
   PubMed Web of Science ®Google Scholar
• WaldstrømMChristensenRKØrnskovDEvaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesionCancer Cytopathol2013121313614522987560
   PubMed Web of Science ®Google Scholar
• AtkinsKp16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytologyCancer Cytopathol2011119314514721442766
   PubMed Web of Science ®Google Scholar
• SahasrabuddheVVLuhnPWentzensenNHuman papillomavirus and cervical cancer: biomarkers for improved prevention effortsFuture Microbiol2011691083109821958146
   PubMed Web of Science ®Google Scholar
• IkenbergHBergeronCSchmidtDScreening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the palms studyJ Natl Cancer Inst2013105201550155724096620
   PubMedGoogle Scholar
• YuLLChenWLeiXQEvaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in ChinaOncotarget2016716211812118927029033
   PubMedGoogle Scholar
• OrdiJSagastaAMunmanyMRodríguez-CarunchioLTornéAdel PinoMUsefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopyCancer Cytopathol2014122322723524757722
   PubMed Web of Science ®Google Scholar
• DonàMGVocaturoAGiulianiMp16/Ki-67 dual staining in cervicovaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopyGynecol Oncol2012126219820222588180
   PubMed Web of Science ®Google Scholar
• PetryKUSchmidtDScherbringSTriaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 dual-stained cytologyGynecol Oncol2011121350550921420158
   PubMed Web of Science ®Google Scholar
• WentzensenNSchwartzLZunaREPerformance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral populationClin Cancer Res201218154154416222675168
   PubMed Web of Science ®Google Scholar
• UijterwaalMHWitteBIvan KemenadeFJTriaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome studyBr J Cancer201411061579158624518601
   PubMed Web of Science ®Google Scholar
• SchmidtDBergeronCDentonKJRidderREuropean CINtec Cytology Study Groupp16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology studyCancer Cytopathol2011119315816621442767
   PubMed Web of Science ®Google Scholar
• BergeronCIkenbergHSideriMProspective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study resultsCancer Cytopathol2015123637338125891096
   PubMed Web of Science ®Google Scholar
• WrightTCStolerMHBehrensCMSharmaAZhangGWrightTLPrimary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening testGynecol Oncol2015136218919725579108
   PubMed Web of Science ®Google Scholar
• WentzensenNFettermanBCastlePEp16/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive womenJ Natl Cancer Inst201510712djv25726376685
   PubMedGoogle Scholar
• WrightTCBehrensCMRanger-MooreJTriaging HPV-positive women with p16/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trialGynecol Oncol20171441515628094038
   PubMed Web of Science ®Google Scholar
• OvestadITDalenIHansenEClinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening ProgramCancer Cytopathol2017125428329127918650
   PubMed Web of Science ®Google Scholar
• ChenYMillerCMosherRIdentification of cervical cancer markers by cDNA and tissue microarraysCancer Res20036381927193512702585
   PubMed Web of Science ®Google Scholar
• BurdenDAOsheroffNMechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzymeBiochim Biophys Acta199814001–31391549748545
   PubMedGoogle Scholar
• SantinADZhanFBignottiEGene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapyVirology2005331226929115629771
   PubMed Web of Science ®Google Scholar
• MurphyNRingMHeffronCCP16INK4a, Cdc6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancerJ Clin Pathol200558552553415858126
   PubMed Web of Science ®Google Scholar
• MalinowskiDPMolecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical diseaseBioTechniques2005384SS17S23
   Google Scholar
• ShroyerKRHomerPHeinzDSinghMValidation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytologyCancer2006108532433016937378
   PubMed Web of Science ®Google Scholar
• KellyDKincaidEFanslerZRosenthalDLClarkDPDetection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C)Cancer2006108649450017063495
   PubMed Web of Science ®Google Scholar
• TambouretRHMisdrajiJWilburDCLongitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimensArch Pathol Lab Med2008132691892518517273
   PubMed Web of Science ®Google Scholar
• AlaghehbandanRFontaineDBentleyJPerformance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytologyDiagn Cytopathol201341976777523341349
   PubMed Web of Science ®Google Scholar
• WaltsAEBoseSP16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasiaHum Pathol200940795796419269017
   PubMed Web of Science ®Google Scholar
• ZhengJDiagnostic value of Mcm2 immunocytochemical staining in cervical lesions and its relationship with HPV infectionInt J Clin Exp Pathol20158187588025755789
   PubMed Web of Science ®Google Scholar
• PeresALE SilvaKMde AraújoRFImmunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological careJ Biomed Sci20162314227175798
   PubMedGoogle Scholar
• GuidoRSchiffmanMSolomonDBurkeLASCUS LSIL Triage Study (ALTS) GroupPostcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective studyAm J Obstet Gynecol200318861401140512824969
   PubMed Web of Science ®Google Scholar
• ByunSWLeeAKimSChoiYJLeeYSParkJSImmunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H casesInt J Med Sci201310121602160724151431
   PubMedGoogle Scholar
• SobelGPáskaCSzabóIKissAKádárASchaffZIncreased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinomaHum Pathol200536216216915754293
   PubMed Web of Science ®Google Scholar
• BenczikMGalambÁKoissRClaudin-1 as a biomarker of cervical cytology and histologyPathol Oncol Res201622117918826463354
   PubMed Web of Science ®Google Scholar
• AttilaMGáborSNándorÁcsZsuzsannaSTímeaSA study about the efficiency of cervical cancer screening using biomarkers p16/Ki67 and claudin 1Eur J Obstet Gynecol Reprod Biol2016206e73
   Web of Science ®Google Scholar
• CrokerBAO’DonnellJANowellCJFas-mediated neutrophil apoptosis is accelerated by bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1Proc Natl Acad Sci USA201110832131351314021768356
   PubMed Web of Science ®Google Scholar
• KlapsinouEArgyriEPanotopoulouEBax and Bak expression in cervical smears of women with low-and high-risk HPV types: a study of 120 casesJ Cytol201532422322926811568
   PubMed Web of Science ®Google Scholar
• PrinceSNFoulstoneEJZaccheoOJWilliamsCHassanABFunctional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptorMol Cancer Ther20076260761717308058
   PubMed Web of Science ®Google Scholar
• WeiQFuBLiuJXuJZhaoTCombined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosisInt J Clin Exp Pathol2013681549155723923073
   PubMed Web of Science ®Google Scholar
• LiCRockKLWodaBAJiangZFraireAEDresserKIMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expressionMod Pathol200720224224717192788
   PubMed Web of Science ®Google Scholar
• LastraRROuJJReillyMEUtility of ProExC and IMP3 immunocytochemical staining in atypical glandular cells of undetermined significance in liquid-based cervical cytologyDiagn Cytopathol201442537537923904388
   PubMed Web of Science ®Google Scholar
• GarnerDClinical application of DNA ploidy to cervical cancer screening: a reviewWorld J Clin Oncol20145593125493231
   PubMedGoogle Scholar
• MellinWCytophotometry in tumor pathology. A critical review of methods and applications, and some results of DNA analysisPathol Res Pract1990186137622179910
   PubMed Web of Science ®Google Scholar
• LiGGuillaudMFollenMMacAulayCDouble staining cytologic samples with quantitative Feulgen-thionin and anti-Ki-67 immunocytochemistry as a method of distinguishing cells with abnormal DNA content from normal cycling cellsAnal Quant Cytol Histol2012345273284
   Google Scholar
• PiriRGhaffariAAzami-AghdashSAli-AkbarYPSalehPNaghavi-BehzadMKi-67/MIB-1 as a prognostic marker in cervical cancer: a systematic review with meta-analysisAsian Pac J Cancer Prev201516166997700226514481
   PubMedGoogle Scholar
• SahebaliSDepuydtCEBouletGAImmunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional studyInt J Cancer200611851254126016161049
   PubMed Web of Science ®Google Scholar
• HuCJZhouLZhangJHuangCZhangGMImmunohistochemical detection of Raf kinase inhibitor protein in normal cervical tissue and cervical cancer tissueJ Int Med Res201139122923721672326
   PubMed Web of Science ®Google Scholar
• MartinhoOPintoFGranjaSRKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapyPLoS One201383e5910423527098
   PubMed Web of Science ®Google Scholar
• Al-AwadhiRHusainSChehadehWAl-JassarWKapilaKAl-MullaFImmunocytochemical detection of Raf kinase inhibitor protein and human papillomavirus profiling of normal and abnormal cervical ThinPrep samplesActa Cytol201357325926523636063
   PubMed Web of Science ®Google Scholar
• AuvinenECarpenOKorpelaTRontyMVaheriATarkkanenJAltered expression of Ezrin, E-cadherin and β-catenin in cervical neoplasiaNeoplasma201260015661
   Google Scholar
• KongJLiYLiuSHigh expression of ezrin predicts poor prognosis in uterine cervical cancerBMC Cancer201313152024182314
   PubMedGoogle Scholar
• LiMFengYMFangSQOverexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancerBraz J Med Biol Res2017504e535628355349
   PubMed Web of Science ®Google Scholar
• FaghihlooESadeghizadehMShahmahmoodiSMokhtari-AzadTCdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expressionCancer Gene Ther Epub20161111
   Google Scholar
• HigashiKUedaYShimasakiMHigh FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinomaAnn Nucl Med201731859059528677069
   PubMed Web of Science ®Google Scholar
• ZhangZBuXChenHWangQShaWBmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherinInt J Mol Med20163841199120727600678
   PubMed Web of Science ®Google Scholar
• Zacapala-GómezAENavarro-TitoNAlarcón-RomeroLDCEzrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancerBMC Cancer201818134929587669
   PubMedGoogle Scholar